— Know what they know.
Not Investment Advice

DKSC OTC

Dakshidin Corporation
1W: +0.0% 1M: +33.3% 3M: +0.0% YTD: +100.0% 1Y: +300.0% 3Y: -20.0% 5Y: -86.7%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Neutral · Power 54 · $1.8M mcap · Short 26% of daily vol

Income Trends

Revenue
$0 +0.0% ▲
Gross Profit
$0 +0.0% ▲
Operating Income
-$18K +89.4% ▲
Net Income
-$18K +89.4% ▲
EPS (Diluted)
$0.00 +100.0% ▲
EBITDA
$150K +189.9% ▲

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2019FY2020FY2021FY2022FY2023
Revenue$19K$208K$2K$0$0
YoY Growth+0.0%+992.2%-98.8%-100.0%+0.0%
Cost of Revenue$0$166K$0$0$0
Gross Profit$19K$42K$2K$0$0
Gross Margin100.0%20.4%100.0%——
R&D Expenses$7K$0$0$0$0
SG&A Expenses$196K$50K$219K$167K$18K
Operating Expenses$202K$50K$219K$167K$18K
Operating Income-$183K-$8K-$217K-$167K-$18K
Operating Margin-961.9%-3.8%-8743.5%——
Interest Expense$0$0$0$0$0
Income Before Tax-$183K-$8K-$217K-$167K-$18K
Tax Expense$0$0$0$0$0
Net Income-$183K-$8K-$217K-$167K-$18K
Net Margin-961.9%-3.8%-8743.4%——
EPS (Diluted)$-0.00$0.00$-0.00$-0.00$0.00
EBITDA-$183K-$8K-$217K-$167K$150K
Shares Outstanding2.50B2.50B2.56B2.58B3.34B

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms